HTX 0.00% 0.1¢ healthlinx limited

Korean trials. If results prove Oviplex 97% better than the...

  1. 2,279 Posts.
    lightbulb Created with Sketch. 5
    Korean trials. If results prove Oviplex 97% better than the traditional CA125 ovarian cancer diagnostic blood tests then HTX is in. Results expected out around June 2011.
 
watchlist Created with Sketch. Add HTX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.